MBD4 and myeloid sarcoma: Significant associations with reduced MS risk were observed for rs1052133 (OGG1, OR = 0.57, p = 0.043), rs2307293 (MBD4, OR = 0.16, p = 0.010), and rs4135054 (TDG, OR = 0.38, p < 0.001).